CARLSBAD, Calif.--(BUSINESS WIRE)--
GenMark Diagnostics, Inc. (NASDAQ:GNMK) today announced that it plans to
release its third quarter earnings results after market close on
Thursday, November 2, 2017. Management will hold a conference call to
review the Company's financial performance starting at 4:30 p.m. ET on
the same day. The conference call will be concurrently webcast. The link
to the webcast will be available on the GenMark Diagnostics, Inc.
website at www.genmarkdx.com
under the investor relations section and will be archived for future
reference. To listen to the conference call, please dial (877) 312-5847
(US/Canada) or (253) 237-1154 (International) and use the conference ID
number 89238764 approximately five minutes prior to the start time.
ABOUT GENMARK DIAGNOSTICS
GenMark Diagnostics (NASDAQ: GNMK) is a leading provider of multiplex
molecular diagnostic solutions designed to enhance patient care, improve
key quality metrics, and reduce the total cost-of-care. Utilizing
GenMark's proprietary eSensor® detection technology, GenMark's eSensor
XT-8® and ePlex® systems are designed to support a broad range of
molecular diagnostic tests with compact, easy-to-use workstations and
self-contained, disposable test cartridges. GenMark's ePlex: The True
Sample-to-Answer Solution™ is designed to optimize laboratory
efficiency and address a broad range of infectious disease testing
needs, including respiratory, bloodstream, and gastrointestinal
infections. For more information, visit www.genmarkdx.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171019006468/en/
GenMark Diagnostics, Inc.
Source: GenMark Diagnostics, Inc.
News Provided by Acquire Media